Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Vet Comp Oncol ; 20(1): 276-292, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34590408

ABSTRACT

The staging system commonly used in canine anal sac gland carcinoma (ASGC) is a revised Tumour-Node-Metastasis (TNM) system published in 2007. This staging system consists in four stages and, for dogs with nodal metastases, the size of the metastatic lymph node (mLN) defines the N stage. However, we hypothesise that (1) the mLN size has no prognostic significance when the mLN can be excised, (2) a high number of mLNs is associated with poorer prognosis and (3) the measurement of the mLN on imaging is not reproducible. To investigate these hypotheses, medical records and diagnostic images of dogs with ASGC and mLN, treated with sacculectomy and lymphadenectomy, with or without chemotherapy, were reviewed. Interobserver variability for mLN measurement was assessed. Prognostic factors including mLN size and number were investigated. Time to documented progression (TDP) and disease-specific survival (DSS) were evaluated. Progression-free interval (PFI) was analysed with interval-censored data analysis. Fifty-seven dogs were included. The median PFI, TDP and DSS were 110 (95%CI 61.5-185.5), 196 (95%CI 162-283) and 340 days (95%CI 321-471), respectively. For measurement of the largest mLN, interobserver agreement was excellent but limits of agreement reached 39.7%. Neither the size of the largest mLN nor the use of adjuvant chemotherapy were associated with outcome. The number of mLNs was associated with outcome and having more than four mLNs was associated with shorter PFI (p < .001), TDP (p = .004) and DSS (p < .001). While mLN size measurement was not consistently reproducible and did not influence outcome in our cohort, number of mLNs did. Further studies are required for development of a revised staging system.


Subject(s)
Anal Sacs , Carcinoma , Dog Diseases , Anal Sacs/pathology , Anal Sacs/surgery , Animals , Carcinoma/pathology , Carcinoma/veterinary , DNA-Binding Proteins , Dog Diseases/drug therapy , Dog Diseases/pathology , Dog Diseases/surgery , Dogs , Lymph Node Excision/veterinary , Lymph Nodes/pathology , Lymph Nodes/surgery , Lymphatic Metastasis/pathology , Neoplasm Staging , Prognosis , Retrospective Studies
2.
J Vet Emerg Crit Care (San Antonio) ; 29(6): 696-701, 2019 Nov.
Article in English | MEDLINE | ID: mdl-31642173

ABSTRACT

OBJECTIVE: To describe a case of successful management of epidural-subdural abscess and severe meningitis with secondary brain herniation in a dog. CASE SUMMARY: A rhino-sinusotomy was performed in a 3-year-old mixed-breed dog for management of refractory sinonasal aspergillosis. Initial recovery was good, but the dog became acutely stuporous 36 hours after surgery. Evidence of increased intracranial pressure with brain herniation and midline shift secondary to an epidural abscess was observed on magnetic resonance imaging. Decompressive craniectomy and drainage of the abscess was performed. Intensive nursing care and physiologic support was performed with consciousness returning 7 days after initial stupor. The dog was discharged 14 days after craniectomy and was ambulatory with support. NEW/UNIQUE INFORMATION PROVIDED: Intracranial abscesses are rarely described in dogs and few had a successful outcome reported. All previous reports have been of brain abscesses or empyema, rather than a combination of epidural and subdural abscessation. Additionally, the process of sino-rhinotomy for management of aspergillosis has not been previously linked to intracranial abscess formation. To the authors' knowledge, this is the first report of successful management of an epidural-subdural abscess and suggests that even with cases with low modified Glasgow Coma Scale scores outcome may be positive.


Subject(s)
Dog Diseases/etiology , Empyema, Subdural/veterinary , Epidural Abscess/veterinary , Escherichia coli Infections/veterinary , Escherichia coli/isolation & purification , Animals , Anti-Bacterial Agents/therapeutic use , Dog Diseases/microbiology , Dogs , Empyema, Subdural/microbiology , Empyema, Subdural/therapy , Epidural Abscess/microbiology , Epidural Abscess/therapy , Escherichia coli Infections/microbiology , Escherichia coli Infections/pathology , Escherichia coli Infections/therapy , Male , Postoperative Complications/microbiology , Postoperative Complications/veterinary
SELECTION OF CITATIONS
SEARCH DETAIL
...